Our mission: Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases. … Continue reading Head of Cell Therapy and Viral Vector Process Development